A-431 In Vitro TRAP Assay (Senescence)

CAT#: ITS-1122-YF1307
Target Cell Organism: Human
Target Cell Alternative Name: A431
Target Cell Name: A-431
Assay Type: Cellular Senescence in Cancer Assays
Assay Overview
This assay is to provide A-431-based In Vitro TRAP Assay (Senescence) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
A-431
Target Cell Organism
Human
Target Cell Background
A-431 is a cell line exhibiting epithelial morphology that was isolated from the epidermis of an 85-year-old female patient with epidermoid carcinoma. This cell line is one of a series of cell lines established from solid tumors by D.J. Giard, et al. and can be used in cancer, toxicology, and immuno-oncology research.
Target Cell Alternative Name
A431
Related Diseases
Epidermoid Carcinoma
Research Area
Oncology
Assay Name
In Vitro TRAP Assay (Senescence)
Short Description
A-431-cell based In Vitro TRAP Assay (Senescence)
Assay Description
The telomerase repeated amplification protocol (TRAP) assay is one of the common PCR-based assays used to detect telomerase activity in cells.
Assay Alternative Names
Telomerase Repeated Amplification Protocol Assay
Assay Type
Cellular Senescence in Cancer Assays
Assay Type Details
Cell senescence is described as an irreversible physiological event of cell growth arrest, which is known to be caused by alterations of telomeres, oxidative stress, DNA damage and some oncogenes. Inhibition of the program of senescence is one of the main features of tumor cells and it has been reported that cancer cells can be induced to undergo senescence by chemo- and radiotherapies and genetic alterations. Telomeres help to prevent uncontrolled cell proliferation and the absence of telomeres results in aneuploidy and cell death.
Assay Subtype
TRAP Assay
For Research Use Only | Not For Clinical Use
Online Inquiry